Tags:BioTechCenterDevelopmentMedicalMedTech
PacingCure BV is an Academic Medical Center (AMC) spin-off biotech company that focuses on the development of clinically applicable biological pacemaker therapies. A biological pacemaker, which incorporates robust sensitivity to autonomic modulation, is devoid of hardware-related complications, has the potential to provide lifelong cure instead of temporary palliation, and can be implanted at a physiological site.
Investors 1
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
11.10.2022 | - | $2.429307M | - | uvaventure... |
Mentions in press and media 3